279 related articles for article (PubMed ID: 12210413)
1. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
[TBL] [Abstract][Full Text] [Related]
2. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
[TBL] [Abstract][Full Text] [Related]
3. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
4. 4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
De Castro S; García-Aparicio C; Andrei G; Snoeck R; Balzarini J; Camarasa MJ; Velázquez S
J Med Chem; 2009 Mar; 52(6):1582-91. PubMed ID: 19226140
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.
Miwa N; Kurosaki K; Yoshida Y; Kurokawa M; Saito S; Shiraki K
Antiviral Res; 2005 Jan; 65(1):49-55. PubMed ID: 15652971
[TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses.
Brideau RJ; Knechtel ML; Huang A; Vaillancourt VA; Vera EE; Oien NL; Hopkins TA; Wieber JL; Wilkinson KF; Rush BD; Schwende FJ; Wathen MW
Antiviral Res; 2002 Apr; 54(1):19-28. PubMed ID: 11888654
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity.
Hartline CB; Harden EA; Williams-Aziz SL; Kushner NL; Brideau RJ; Kern ER
Antiviral Res; 2005 Feb; 65(2):97-105. PubMed ID: 15708636
[TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence-based antiviral assay for the evaluation of compounds against vaccinia virus, varicella zoster virus and human cytomegalovirus.
Dal Pozzo F; Andrei G; Daelemans D; Winkler M; Piette J; De Clercq E; Snoeck R
J Virol Methods; 2008 Jul; 151(1):66-73. PubMed ID: 18490063
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
11. Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes.
Bakker-Woudenberg IA; Lokerse AF; ten Kate M
Scand J Infect Dis Suppl; 1990; 74():54-7. PubMed ID: 1965866
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.
Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K
Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502
[TBL] [Abstract][Full Text] [Related]
13. Influence of 6- or 8-substitution on the antiviral activity of 3-arylalkylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (CMV) and varicella-zoster virus (VZV): part II.
Véron JB; Allouchi H; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
Bioorg Med Chem; 2008 Nov; 16(21):9536-45. PubMed ID: 18835175
[TBL] [Abstract][Full Text] [Related]
14. Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV).
Véron JB; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
Bioorg Med Chem; 2007 Nov; 15(22):7209-19. PubMed ID: 17869124
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of antiviral resistance among the herpesvirus group].
Reina J
Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
[No Abstract] [Full Text] [Related]
16. Synthesis and anti-VZV activity of 6-heteroaryl derivatives of tricyclic acyclovir and 9-{[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl}guanine analogues.
Ostrowski T; Golankiewicz B; De Clercq E; Andrei G; Snoeck R
Eur J Med Chem; 2009 Aug; 44(8):3313-7. PubMed ID: 19339082
[TBL] [Abstract][Full Text] [Related]
17. Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine.
Ng TI; Shi Y; Huffaker HJ; Kati W; Liu Y; Chen CM; Lin Z; Maring C; Kohlbrenner WE; Molla A
Antimicrob Agents Chemother; 2001 Jun; 45(6):1629-36. PubMed ID: 11353604
[TBL] [Abstract][Full Text] [Related]
18. [In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall R; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Jun; 14(2):155-64. PubMed ID: 11704769
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antiviral activity of different origin compounds by flow cytometry.
Siennicka J; Trzcińska A; Kańtoch M
Acta Microbiol Pol; 2002; 51(1):79-83. PubMed ID: 12184452
[TBL] [Abstract][Full Text] [Related]
20. [Resistance to virostatic agents in Herpes viruses: mechanism, incidence and clinical significance].
Reusser P
Schweiz Med Wochenschr; 1994 Jan; 124(4):152-8. PubMed ID: 8128197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
